Abstract |
Signaling through the IL-17 receptor (IL-17R) is required to prevent oropharyngeal candidiasis (OPC) in mice and humans. However, the IL-17-responsive cell type(s) that mediate protection are unknown. Using radiation chimeras, we were able to rule out a requirement for IL-17RA in the hematopoietic compartment. We saw remarkable concordance of IL-17-controlled gene expression in C. albicans-infected human oral epithelial cells (OECs) and in tongue tissue from mice with OPC. To interrogate the role of the IL-17R in OECs, we generated mice with conditional deletion of IL-17RA in superficial oral and esophageal epithelial cells (Il17raΔK13). Following oral Candida infection, Il17raΔK13 mice exhibited fungal loads and weight loss indistinguishable from Il17ra-/- mice. Susceptibility in Il17raΔK13 mice correlated with expression of the antimicrobial peptide β- defensin 3 (BD3, Defb3). Consistently, Defb3-/- mice were susceptible to OPC. Thus, OECs dominantly control IL-17R-dependent responses to OPC through regulation of BD3 expression.
|
Authors | Heather R Conti, Vincent M Bruno, Erin E Childs, Sean Daugherty, Joseph P Hunter, Bemnet G Mengesha, Danielle L Saevig, Matthew R Hendricks, Bianca M Coleman, Lucas Brane, Norma Solis, J Agustin Cruz, Akash H Verma, Abhishek V Garg, Amy G Hise, Jonathan P Richardson, Julian R Naglik, Scott G Filler, Jay K Kolls, Satrajit Sinha, Sarah L Gaffen |
Journal | Cell host & microbe
(Cell Host Microbe)
Vol. 20
Issue 5
Pg. 606-617
(Nov 09 2016)
ISSN: 1934-6069 [Electronic] United States |
PMID | 27923704
(Publication Type: Journal Article)
|
Copyright | Copyright © 2016 Elsevier Inc. All rights reserved. |
Chemical References |
- Il17ra protein, mouse
- Receptors, Interleukin-17
- beta-Defensins
- beta-defensin 3, mouse
|
Topics |
- Animals
- Candida
(immunology)
- Candidiasis, Oral
(immunology)
- Cell Line
- Epithelial Cells
(immunology)
- Humans
- Mice
- Mice, Knockout
- Mouth Mucosa
(immunology)
- Receptors, Interleukin-17
(deficiency, metabolism)
- Signal Transduction
- beta-Defensins
(metabolism)
|